logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kohei Hashimoto

Sapporo Medical University
H指数:18
被引数:1,455

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC

在转移性CRPC中，达到CRPC前达到的最低PSA水平可预测阿比特龙的治疗反应，但不能预测恩扎卢amide的治疗反应

Prostate
IF2.5
2026-09-290
PRE
Kohei Hashimoto; Kouji Izumi; Takashi Shima; Yuki Kato; Koji Mita; Takehiko Okamura; Shogo Inoue; Shuichi Tatarano; Nobumichi Tanaka; Noriyasu Kawai; Manabu Kamiyama; Ippei Chikazawa; Seiji Hoshi; Takashi Fukagai; Kazuyoshi Shigehara; Shizuko Takahara; Atsushi Mizokami
Prognostic impact of diabetes or hypertension in smokers with CRPC receiving enzalutamide or abiraterone

吸烟的转移性去势抵抗性前列腺癌患者接受恩扎卢替尼或阿比特龙治疗时，糖尿病或高血压的预后影响

International Journal of Clinical Oncology
IF2.8
2026-09-190
PRE
Takashi Fukagai; Kouji Izumi; Motoki Yamagishi; Takashi Shima; Yuki Kato; Koji Mita; Takehiko Okamura; Shogo Inoue; Shuichi Tatarano; Nobumichi Tanaka; Noriyasu Kawai; Manabu Kamiyama; Ippei Chikazawa; Seiji Hoshi; Kohei Hashimoto; Kazuyoshi Shigehara; Shizuko Takahara; Atsushi Mizokami
Comparison of Urodynamic Outcomes of Surgery Using the Photoselective Vaporization 180 W XPS System and Transurethral Resection of the Prostate: A Propensity Score-Matched Analysis in Real-World Clinical Practice

使用180 W XPS系统光选择性汽化与经尿道前列腺切除术的尿动力学结果比较：一项真实世界临床实践中的倾向性评分匹配分析

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2026-05-280
PRE
Saito, Yoko; Kyoda, Yuki; Nofuji, Seisuke; Shibamori, Kosuke; Tabata, Hidetoshi; Hashimoto, Kohei; Kobayashi, Ko; Tanaka, Toshiaki; Masumori, Naoya
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa

恩扎卢替尼和阿比特龙在既往有其他癌症史的患者中的有效性和安全性：针对PCa的ENABLE研究的亚组分析

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2026-05-201
PRE
Hoshi, Seiji; Izumi, Kouji; Meguro, Satoru; Shima, Takashi; Kato, Yuki; Mita, Koji; Okamura, Takehiko; Inoue, Shogo; Tatarano, Shuichi; Tanaka, Nobumichi; Yoshio, Yuko; Kamiyama, Manabu; Chikazawa, Ippei; Kawai, Noriyasu; Hashimoto, Kohei; Fukagai, Takashi; Shigehara, Kazuyoshi; Takahara, Shizuko; Mizokami, Atsushi
Risk Assessment of Non-Urinary Tract Recurrence After Radical Nephroureterectomy Based on CheckMate 274 Trial Eligibility: A Multicenter Retrospective Study

基于CheckMate 274试验入组标准的根治性肾输尿管切除术后的非泌尿道复发风险评估：一项多中心回顾性研究

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2026-05-140
OAAI
Shindo, Tetsuya; Ueki, Yohei; Muranaka, Ippei; Kobayashi, Genki; Miyamoto, Shintaro; Kunishima, Yasuharu; Sato, Shunsuke; Okada, Manabu; Kato, Shuichi; Kato, Ryuichi; Adachi, Hideki; Matsukawa, Masanori; Takayanagi, Akio; Shibamori, Kosuke; Wanifuchi, Atsushi; Kyoda, Yuki; Hashimoto, Kohei; Kobayashi, Ko; Tanaka, Toshiaki; Masumori, Naoya
Optimal Timing of Treatment Initiation in Non-Metastatic Castration-Resistant Prostate Cancer Based on PSA Level and Doubling Time for Prognostic Benefit

基于PSA水平和倍增时间，以获得预后益处，非转移性去势抵抗性前列腺癌治疗起始的最佳时机

Cancers 2025, Vol. 17, Page 3641
IF4.4
2025-11-180
OAAI
Takuto Ogasawara; Kohei Hashimoto; Tetsuya Shindo; Ko Kobayashi; Toshiaki Tanaka; Fumimasa Fukuta; Genki Kobayashi; Ryuichi Kato; Shintaro Miyamoto; Yasuharu Kunishima; Naoya Masumori
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study

enfortumab vedotin治疗老年转移性尿路上皮癌的疗效和安全性: 一项多中心回顾性研究

JOURNAL OF GERIATRIC ONCOLOGY
IF2.7
2025-03-010
PRE
Shindo, Tetsuya; Hashimoto, Kohei; Kenuka, Toshiki; Miyamoto, Shintaro; Hiyama, Yoshiki; Fukuta, Fumimasa; Kunishima, Yasuharu; Okada, Manabu; Matsukawa, Masanori; Kato, Ryuichi; Senda, Masaya; Wanifuchi, Atsushi; Sato, Shunsuke; Kobayashi, Ko; Tanaka, Toshiaki; Masumori, Naoya
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy
ANNALS OF SURGICAL ONCOLOGY
IF3.5
2024-02-141
PRE
Shiota, Masaki; Takamatsu, Dai; Matsui, Yoshiyuki; Yokomizo, Akira; Morizane, Shuichi; Saito, Ryoichi; Miyake, Makito; Tsutsumi, Masakazu; Yamamoto, Yoshiyuki; Tashiro, Kojiro; Tomida, Ryotaro; Narita, Shintaro; Edamura, Kohei; Yamaguchi, Takahiro; Hashimoto, Kohei; Kato, Masashi; Kasahara, Takashi; Yoshino, Takayuki; Akamatsu, Shusuke; Kaneko, Tomoyuki; Matsukawa, Akihiro; Matsumoto, Ryuji; Joraku, Akira; Saito, Toshihiro; Kato, Takuma; Kato, Manabu; Enokida, Hideki; Sakamoto, Shinichi; Terada, Naoki; Kanno, Hidenori; Nishiyama, Naotaka; Kimura, Takahiro; Kitamura, Hiroshi; Eto, Masatoshi
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial
EUROPEAN UROLOGY OPEN SCIENCE
IF4.5
2022-07-0110
OAAI
Izumi, Kouji; Shima, Takashi; Mita, Koji; Kato, Yuki; Kamiyama, Manabu; Inoue, Shogo; Tanaka, Nobumichi; Hoshi, Seiji; Okamura, Takehiko; Yoshio, Yuko; Enokida, Hideki; Chikazawa, Ippei; Kawai, Noriyasu; Hashimoto, Kohei; Fukagai, Takashi; Shigehara, Kazuyoshi; Takahara, Shizuko; Kadono, Yoshifumi; Mizokami, Atsushi
Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro
BIOMATERIALS
IF12.9
2019-03-0141
OAAI
Pereira, Brooke A.; Lister, Natalie L.; Hashimoto, Kohei; Teng, Linda; Flandes-Iparraguirre, Maria; Eder, Angelina; Sanchez-Herrero, Alvaro; Niranjan, Birunthi; Frydenberg, Mark; Papargiris, Melissa M.; Lawrence, Mitchell G.; Taylor, Renea A.; Hutmacher, Dietmar W.; Ellem, Stuart J.; Risbridger, Gail P.; De-Juan-Pardo, Elena M.

研究方向

暂未获取到该数据
N
Naoya Masumori
H 指数:45论文数:659被引数:1.0万
T
Toshiaki Tanaka
H 指数:34论文数:448被引数:5,227
K
Ko Kobayashi
H 指数:19论文数:146被引数:1,324
T
Taiji Tsukamoto
H 指数:50论文数:634被引数:1.0万
S
Shin‐ichi Hisasue
H 指数:22论文数:156被引数:1,668
T
Tetsuya Shindo
H 指数:16论文数:142被引数:876
Y
Yuki Kyoda
H 指数:7论文数:63被引数:146
K
Kouji Izumi
H 指数:34论文数:317被引数:5,729
N
Nobumichi Tanaka
H 指数:33论文数:384被引数:4,382
T
T. Okamura
H 指数:17论文数:247被引数:1,361